chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Dysphonia, Fatigue, Headache
Clinical narrative: post nasal drip; sinus pressure around my eyes; no appetite; runny eyes; Headache; Felt tired; Chills; Sneezing so much; sinus congestion; hoarseness; runny nose; puffy eyes; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing so much), SINUS CONGESTION (sinus congestion), DYSPHONIA (hoarseness), RHINORRHOEA (runny nose) and PERIORBITAL SWELLING (puffy eyes) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0041720A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.    On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced SNEEZING (Sneezing so much), SINUS CONGESTION (sinus congestion), DYSPHONIA (hoarseness), RHINORRHOEA (runny nose), PERIORBITAL SWELLING (puffy eyes), HEADACHE (Headache), FATIGUE (Felt tired) and CHILLS (Chills). On 16-Mar-2021, the patient experienced DECREASED APPETITE (no appetite) and LACRIMATION INCREASED (runny eyes). On 17-Mar-2021, the patient experienced PARANASAL SINUS DISCOMFORT (sinus pressure around my eyes) and UPPER-AIRWAY COUGH SYNDROME (post nasal drip). The patient was treated with GUAIFENESIN (MUCINEX) ongoing since an unknown date at a dose of 1200 mg and LORATADINE (CLARITINE) at a dose of UNK dosage form. At the time of the report, SNEEZING (Sneezing so much), SINUS CONGESTION (sinus congestion), DYSPHONIA (hoarseness), RHINORRHOEA (runny nose), PERIORBITAL SWELLING (puffy eyes), PARANASAL SINUS DISCOMFORT (sinus pressure around my eyes), DECREASED APPETITE (no appetite), UPPER-AIRWAY COUGH SYNDROME (post nasal drip), LACRIMATION INCREASED (runny eyes), HEADACHE (Headache), FATIGUE (Felt tired) and CHILLS (Chills) outcome was unknown.            No Concomitant Medication was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Lacrimation increased, Paranasal sinus discomfort, Periorbital swelling, Rhinorrhoea, Sinus congestion
Clinical narrative: post nasal drip; sinus pressure around my eyes; no appetite; runny eyes; Headache; Felt tired; Chills; Sneezing so much; sinus congestion; hoarseness; runny nose; puffy eyes; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing so much), SINUS CONGESTION (sinus congestion), DYSPHONIA (hoarseness), RHINORRHOEA (runny nose) and PERIORBITAL SWELLING (puffy eyes) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0041720A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.    On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced SNEEZING (Sneezing so much), SINUS CONGESTION (sinus congestion), DYSPHONIA (hoarseness), RHINORRHOEA (runny nose), PERIORBITAL SWELLING (puffy eyes), HEADACHE (Headache), FATIGUE (Felt tired) and CHILLS (Chills). On 16-Mar-2021, the patient experienced DECREASED APPETITE (no appetite) and LACRIMATION INCREASED (runny eyes). On 17-Mar-2021, the patient experienced PARANASAL SINUS DISCOMFORT (sinus pressure around my eyes) and UPPER-AIRWAY COUGH SYNDROME (post nasal drip). The patient was treated with GUAIFENESIN (MUCINEX) ongoing since an unknown date at a dose of 1200 mg and LORATADINE (CLARITINE) at a dose of UNK dosage form. At the time of the report, SNEEZING (Sneezing so much), SINUS CONGESTION (sinus congestion), DYSPHONIA (hoarseness), RHINORRHOEA (runny nose), PERIORBITAL SWELLING (puffy eyes), PARANASAL SINUS DISCOMFORT (sinus pressure around my eyes), DECREASED APPETITE (no appetite), UPPER-AIRWAY COUGH SYNDROME (post nasal drip), LACRIMATION INCREASED (runny eyes), HEADACHE (Headache), FATIGUE (Felt tired) and CHILLS (Chills) outcome was unknown.            No Concomitant Medication was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing, Upper-airway cough syndrome
Clinical narrative: post nasal drip; sinus pressure around my eyes; no appetite; runny eyes; Headache; Felt tired; Chills; Sneezing so much; sinus congestion; hoarseness; runny nose; puffy eyes; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing so much), SINUS CONGESTION (sinus congestion), DYSPHONIA (hoarseness), RHINORRHOEA (runny nose) and PERIORBITAL SWELLING (puffy eyes) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0041720A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.    On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced SNEEZING (Sneezing so much), SINUS CONGESTION (sinus congestion), DYSPHONIA (hoarseness), RHINORRHOEA (runny nose), PERIORBITAL SWELLING (puffy eyes), HEADACHE (Headache), FATIGUE (Felt tired) and CHILLS (Chills). On 16-Mar-2021, the patient experienced DECREASED APPETITE (no appetite) and LACRIMATION INCREASED (runny eyes). On 17-Mar-2021, the patient experienced PARANASAL SINUS DISCOMFORT (sinus pressure around my eyes) and UPPER-AIRWAY COUGH SYNDROME (post nasal drip). The patient was treated with GUAIFENESIN (MUCINEX) ongoing since an unknown date at a dose of 1200 mg and LORATADINE (CLARITINE) at a dose of UNK dosage form. At the time of the report, SNEEZING (Sneezing so much), SINUS CONGESTION (sinus congestion), DYSPHONIA (hoarseness), RHINORRHOEA (runny nose), PERIORBITAL SWELLING (puffy eyes), PARANASAL SINUS DISCOMFORT (sinus pressure around my eyes), DECREASED APPETITE (no appetite), UPPER-AIRWAY COUGH SYNDROME (post nasal drip), LACRIMATION INCREASED (runny eyes), HEADACHE (Headache), FATIGUE (Felt tired) and CHILLS (Chills) outcome was unknown.            No Concomitant Medication was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Cough, Dry skin, Influenza like illness, Lacrimation increased
Clinical narrative: Cough all day and night; The baby finger and the ring finger turned green; Head was spinning; Fever; Right arm was severely swollen; Asthma worsen; Lungs whistle; Phlegm on the chest; Flu like symptoms worsend; Cant bend over because everything goes outside of the nose; Itching; I'm in tears; Skin is extremely dry; Fingers hurt all the time; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHMA (Asthma worsen), WHEEZING (Lungs whistle), SKIN DISCOLOURATION (The baby finger and the ring finger turned green), VERTIGO (Head was spinning) and COUGH (Cough all day and night) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pneumonia. Concurrent medical conditions included G6PD deficiency, Drug allergy (allergic to 203 drugs) and Asthma.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced ASTHMA (Asthma worsen), WHEEZING (Lungs whistle), PRODUCTIVE COUGH (Phlegm on the chest), INFLUENZA LIKE ILLNESS (Flu like symptoms worsend), RHINORRHOEA (Cant bend over because everything goes outside of the nose), PRURITUS (Itching), LACRIMATION INCREASED (I'm in tears), DRY SKIN (Skin is extremely dry) and PAIN IN EXTREMITY (Fingers hurt all the time). On 19-Feb-2021, the patient experienced VERTIGO (Head was spinning), PYREXIA (Fever) and VACCINATION SITE SWELLING (Right arm was severely swollen). On 21-Feb-2021, the patient experienced SKIN DISCOLOURATION (The baby finger and the ring finger turned green) and COUGH (Cough all day and night). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and LIDOCAINE for Adverse event, at an unspecified dose and frequency. At the time of the report, ASTHMA (Asthma worsen), WHEEZING (Lungs whistle), SKIN DISCOLOURATION (The baby finger and the ring finger turned green), VERTIGO (Head was spinning), COUGH (Cough all day and night), PRODUCTIVE COUGH (Phlegm on the chest), INFLUENZA LIKE ILLNESS (Flu like symptoms worsend), RHINORRHOEA (Cant bend over because everything goes outside of the nose), PRURITUS (Itching), LACRIMATION INCREASED (I'm in tears), DRY SKIN (Skin is extremely dry), PAIN IN EXTREMITY (Fingers hurt all the time), PYREXIA (Fever) and VACCINATION SITE SWELLING (Right arm was severely swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment details included hydrochloride.   This case was linked to MOD-2021-049714 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Productive cough, Pruritus, Pyrexia, Rhinorrhoea
Clinical narrative: Cough all day and night; The baby finger and the ring finger turned green; Head was spinning; Fever; Right arm was severely swollen; Asthma worsen; Lungs whistle; Phlegm on the chest; Flu like symptoms worsend; Cant bend over because everything goes outside of the nose; Itching; I'm in tears; Skin is extremely dry; Fingers hurt all the time; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHMA (Asthma worsen), WHEEZING (Lungs whistle), SKIN DISCOLOURATION (The baby finger and the ring finger turned green), VERTIGO (Head was spinning) and COUGH (Cough all day and night) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pneumonia. Concurrent medical conditions included G6PD deficiency, Drug allergy (allergic to 203 drugs) and Asthma.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced ASTHMA (Asthma worsen), WHEEZING (Lungs whistle), PRODUCTIVE COUGH (Phlegm on the chest), INFLUENZA LIKE ILLNESS (Flu like symptoms worsend), RHINORRHOEA (Cant bend over because everything goes outside of the nose), PRURITUS (Itching), LACRIMATION INCREASED (I'm in tears), DRY SKIN (Skin is extremely dry) and PAIN IN EXTREMITY (Fingers hurt all the time). On 19-Feb-2021, the patient experienced VERTIGO (Head was spinning), PYREXIA (Fever) and VACCINATION SITE SWELLING (Right arm was severely swollen). On 21-Feb-2021, the patient experienced SKIN DISCOLOURATION (The baby finger and the ring finger turned green) and COUGH (Cough all day and night). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and LIDOCAINE for Adverse event, at an unspecified dose and frequency. At the time of the report, ASTHMA (Asthma worsen), WHEEZING (Lungs whistle), SKIN DISCOLOURATION (The baby finger and the ring finger turned green), VERTIGO (Head was spinning), COUGH (Cough all day and night), PRODUCTIVE COUGH (Phlegm on the chest), INFLUENZA LIKE ILLNESS (Flu like symptoms worsend), RHINORRHOEA (Cant bend over because everything goes outside of the nose), PRURITUS (Itching), LACRIMATION INCREASED (I'm in tears), DRY SKIN (Skin is extremely dry), PAIN IN EXTREMITY (Fingers hurt all the time), PYREXIA (Fever) and VACCINATION SITE SWELLING (Right arm was severely swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment details included hydrochloride.   This case was linked to MOD-2021-049714 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration, Vaccination site swelling, Vertigo, Wheezing
Clinical narrative: Cough all day and night; The baby finger and the ring finger turned green; Head was spinning; Fever; Right arm was severely swollen; Asthma worsen; Lungs whistle; Phlegm on the chest; Flu like symptoms worsend; Cant bend over because everything goes outside of the nose; Itching; I'm in tears; Skin is extremely dry; Fingers hurt all the time; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHMA (Asthma worsen), WHEEZING (Lungs whistle), SKIN DISCOLOURATION (The baby finger and the ring finger turned green), VERTIGO (Head was spinning) and COUGH (Cough all day and night) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pneumonia. Concurrent medical conditions included G6PD deficiency, Drug allergy (allergic to 203 drugs) and Asthma.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced ASTHMA (Asthma worsen), WHEEZING (Lungs whistle), PRODUCTIVE COUGH (Phlegm on the chest), INFLUENZA LIKE ILLNESS (Flu like symptoms worsend), RHINORRHOEA (Cant bend over because everything goes outside of the nose), PRURITUS (Itching), LACRIMATION INCREASED (I'm in tears), DRY SKIN (Skin is extremely dry) and PAIN IN EXTREMITY (Fingers hurt all the time). On 19-Feb-2021, the patient experienced VERTIGO (Head was spinning), PYREXIA (Fever) and VACCINATION SITE SWELLING (Right arm was severely swollen). On 21-Feb-2021, the patient experienced SKIN DISCOLOURATION (The baby finger and the ring finger turned green) and COUGH (Cough all day and night). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and LIDOCAINE for Adverse event, at an unspecified dose and frequency. At the time of the report, ASTHMA (Asthma worsen), WHEEZING (Lungs whistle), SKIN DISCOLOURATION (The baby finger and the ring finger turned green), VERTIGO (Head was spinning), COUGH (Cough all day and night), PRODUCTIVE COUGH (Phlegm on the chest), INFLUENZA LIKE ILLNESS (Flu like symptoms worsend), RHINORRHOEA (Cant bend over because everything goes outside of the nose), PRURITUS (Itching), LACRIMATION INCREASED (I'm in tears), DRY SKIN (Skin is extremely dry), PAIN IN EXTREMITY (Fingers hurt all the time), PYREXIA (Fever) and VACCINATION SITE SWELLING (Right arm was severely swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment details included hydrochloride.   This case was linked to MOD-2021-049714 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Secretion discharge
Clinical narrative: mucus; Allergy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient family member or friend and describes the occurrence of SECRETION DISCHARGE (mucus) and HYPERSENSITIVITY (Allergy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SECRETION DISCHARGE (mucus) and HYPERSENSITIVITY (Allergy). At the time of the report, SECRETION DISCHARGE (mucus) and HYPERSENSITIVITY (Allergy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter.  The reporter noted the patient received the first dose of mRNA-1273 a month prior to the event.  Treatment information was not provided.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pruritus, Rash
Clinical narrative: itching; "a rash for the whole body"; Headache; This spontaneous case was reported by a health care professional and describes the occurrence of HEADACHE (Headache), PRURITUS (itching) and RASH ("a rash for the whole body") in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced HEADACHE (Headache). On 08-Mar-2021, the patient experienced PRURITUS (itching) and RASH ("a rash for the whole body"). On 05-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, PRURITUS (itching) and RASH ("a rash for the whole body") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: With the 1st she got arm pain for 4 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (With the 1st she got arm pain for 4 days) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (With the 1st she got arm pain for 4 days). On 18-Feb-2021, PAIN IN EXTREMITY (With the 1st she got arm pain for 4 days) had resolved.            The action taken with mRNA-1273 (COVID-19 Vaccine Moderna) (Unknown) was not applicable.  Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-049547 (Patient Link).
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dysgeusia
Clinical narrative: Chills; Metallic taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste in mouth) and CHILLS (Chills) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.  Concurrent medical conditions included Diabetes.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-1900, the patient experienced DYSGEUSIA (Metallic taste in mouth). On 16-Mar-2021, the patient experienced CHILLS (Chills). On 16-Mar-2021, CHILLS (Chills) had resolved. At the time of the report, DYSGEUSIA (Metallic taste in mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported was the patient was taking blood pressure, antidiabetic and cholesterol medicines on daily basis.  No treatment medication was reported.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Extreme Arm Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Extreme Arm Pain) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (Extreme Arm Pain). On 18-Mar-2021, PAIN IN EXTREMITY (Extreme Arm Pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test, Prenatal screening test, Ultrasound scan
Clinical narrative: Pregnant patient; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant patient) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 18-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 21-Sep-2020 and the estimated date of delivery was 28-Jun-2021. On 18-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant patient). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fifth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant patient) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Oct-2020, Pregnancy test: other (Positive) Positive. On an unknown date, Prenatal screening test: unknown (Inconclusive) Unknown. On an unknown date, Ultrasound scan: unknown (Inconclusive) Unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Exposure during pregnancy, Injection site pain
Clinical narrative: Felt dizzy within 30 minutes of injection; Exposure during pregnancy; Pain on injection arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of DIZZINESS (Felt dizzy within 30 minutes of injection), EXPOSURE DURING PREGNANCY (Exposure during pregnancy) and INJECTION SITE PAIN (Pain on injection arm) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included Ultrasound fetal (Normal) in December 2020, Non-invasive prenatal testing in December 2020 and Term birth on 13-Jul-2018. Concurrent medical conditions included Drug allergy (Keflex).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in September 2020 and the estimated date of delivery was 21-Jun-2021. On 16-Mar-2021, the patient experienced DIZZINESS (Felt dizzy within 30 minutes of injection), EXPOSURE DURING PREGNANCY (Exposure during pregnancy) and INJECTION SITE PAIN (Pain on injection arm). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 16-Mar-2021, EXPOSURE DURING PREGNANCY (Exposure during pregnancy) had resolved. At the time of the report, DIZZINESS (Felt dizzy within 30 minutes of injection) and INJECTION SITE PAIN (Pain on injection arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided.  The patient had a positive pregnancy test on 02 Oct 2020. No treatment information provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Vaccination site mass, Vaccination site warmth
Clinical narrative: Burning inside of left arm; Raised bump at the injection site size of 50 cent coin; Tiredness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Burning inside of left arm), VACCINATION SITE MASS (Raised bump at the injection site size of 50 cent coin), FATIGUE (Tiredness) and NAUSEA (Nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03682IA) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Burning inside of left arm), VACCINATION SITE MASS (Raised bump at the injection site size of 50 cent coin), FATIGUE (Tiredness) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Burning inside of left arm), VACCINATION SITE MASS (Raised bump at the injection site size of 50 cent coin), FATIGUE (Tiredness) and NAUSEA (Nausea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: a itchy warm to touch rash at injection site; swelling/hardness at injection site; a itchy warm to touch rash at injection site; a itchy warm to touch rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (a itchy warm to touch rash at injection site), VACCINATION SITE SWELLING (swelling/hardness at injection site), VACCINATION SITE PRURITUS (a itchy warm to touch rash at injection site) and VACCINATION SITE RASH (a itchy warm to touch rash at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE WARMTH (a itchy warm to touch rash at injection site), VACCINATION SITE SWELLING (swelling/hardness at injection site), VACCINATION SITE PRURITUS (a itchy warm to touch rash at injection site) and VACCINATION SITE RASH (a itchy warm to touch rash at injection site). At the time of the report, VACCINATION SITE WARMTH (a itchy warm to touch rash at injection site), VACCINATION SITE SWELLING (swelling/hardness at injection site), VACCINATION SITE PRURITUS (a itchy warm to touch rash at injection site) and VACCINATION SITE RASH (a itchy warm to touch rash at injection site) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment included alcohol.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia, Nasopharyngitis, Vaccination site urticaria
Clinical narrative: shoulder pain/joint pain; headache; Joint and muscle pain; cold; Little Lump; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder pain/joint pain), NASOPHARYNGITIS (cold), VACCINATION SITE URTICARIA (Little Lump), HEADACHE (headache) and MYALGIA (Joint and muscle pain) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced NASOPHARYNGITIS (cold) and VACCINATION SITE URTICARIA (Little Lump). On 16-Mar-2021, the patient experienced ARTHRALGIA (shoulder pain/joint pain) and MYALGIA (Joint and muscle pain). 16-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 16-Mar-2021, NASOPHARYNGITIS (cold) and VACCINATION SITE URTICARIA (Little Lump) had resolved. At the time of the report, ARTHRALGIA (shoulder pain/joint pain), HEADACHE (headache) and MYALGIA (Joint and muscle pain) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-049535 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Second dose wasn't received and more than 36 days have passed since then; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose wasn't received and more than 36 days have passed since then) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose wasn't received and more than 36 days have passed since then). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose wasn't received and more than 36 days have passed since then) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that "she missed second dose because this day she stayed in hospital for reason not related to vaccination".  No concomitant medication was not reported. No treatment medication was not reported
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Patient pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Patient pregnant) in a 32-year-old female patient (gravida 4, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 20-Aug-2021. On 08-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Patient pregnant). On 08-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Patient pregnant) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   She was 17 weeks pregnant.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph nodes under her arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes under her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes under her arm). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes under her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Product dose omission issue, Scab, Urticaria
Clinical narrative: 2nd dose which was not given; Numbness; Scab on injection site; Hives on arm; This spontaneous case was reported by a nurse and describes the occurrence of HYPOAESTHESIA (Numbness), SCAB (Scab on injection site), URTICARIA (Hives on arm) and PRODUCT DOSE OMISSION ISSUE (2nd dose which was not given) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness), SCAB (Scab on injection site) and URTICARIA (Hives on arm). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose which was not given). At the time of the report, HYPOAESTHESIA (Numbness), SCAB (Scab on injection site) and URTICARIA (Hives on arm) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (2nd dose which was not given) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow up received and it was reported that the patient didn't take the second dose.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Vaccination site erythema
Clinical narrative: Cough; Chest Congestion; Injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), CHEST DISCOMFORT (Chest Congestion) and VACCINATION SITE ERYTHEMA (Injection site redness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 043L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site redness). On 02-Mar-2021, the patient experienced COUGH (Cough) and CHEST DISCOMFORT (Chest Congestion). At the time of the report, COUGH (Cough), CHEST DISCOMFORT (Chest Congestion) and VACCINATION SITE ERYTHEMA (Injection site redness) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to MOD-2021-049529 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Dizziness, Fatigue
Clinical narrative: severe diarrhea; severe chills then a sudden feeling of hotness; still felt weak; lightheaded; severe body and muscle aches; severe throwing up; severe chills; severe headache; tried to work a little but she couldn't; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (severe diarrhea), FEELING HOT (severe chills then a sudden feeling of hotness), ASTHENIA (still felt weak), DIZZINESS (lightheaded) and MYALGIA (severe body and muscle aches) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arm operation (surgery on her right arm). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced DIARRHOEA (severe diarrhea), FEELING HOT (severe chills then a sudden feeling of hotness), ASTHENIA (still felt weak), DIZZINESS (lightheaded), MYALGIA (severe body and muscle aches), VOMITING (severe throwing up), CHILLS (severe chills), HEADACHE (severe headache) and FATIGUE (tried to work a little but she couldn't). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (severe diarrhea), FEELING HOT (severe chills then a sudden feeling of hotness), MYALGIA (severe body and muscle aches), VOMITING (severe throwing up), CHILLS (severe chills) and HEADACHE (severe headache) had resolved and ASTHENIA (still felt weak), DIZZINESS (lightheaded) and FATIGUE (tried to work a little but she couldn't) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication include Excedrin for Headache.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD21-057451, MOD-2021-049504 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Myalgia, Vomiting
Clinical narrative: severe diarrhea; severe chills then a sudden feeling of hotness; still felt weak; lightheaded; severe body and muscle aches; severe throwing up; severe chills; severe headache; tried to work a little but she couldn't; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (severe diarrhea), FEELING HOT (severe chills then a sudden feeling of hotness), ASTHENIA (still felt weak), DIZZINESS (lightheaded) and MYALGIA (severe body and muscle aches) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arm operation (surgery on her right arm). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced DIARRHOEA (severe diarrhea), FEELING HOT (severe chills then a sudden feeling of hotness), ASTHENIA (still felt weak), DIZZINESS (lightheaded), MYALGIA (severe body and muscle aches), VOMITING (severe throwing up), CHILLS (severe chills), HEADACHE (severe headache) and FATIGUE (tried to work a little but she couldn't). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (severe diarrhea), FEELING HOT (severe chills then a sudden feeling of hotness), MYALGIA (severe body and muscle aches), VOMITING (severe throwing up), CHILLS (severe chills) and HEADACHE (severe headache) had resolved and ASTHENIA (still felt weak), DIZZINESS (lightheaded) and FATIGUE (tried to work a little but she couldn't) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication include Excedrin for Headache.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD21-057451, MOD-2021-049504 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: Kink on neck; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Kink on neck) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic arthritis.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced NECK PAIN (Kink on neck). The patient was treated with IBUPROFEN (oral) ongoing since an unknown date for Neck pain, at an unspecified dose and frequency. At the time of the report, NECK PAIN (Kink on neck) outcome was unknown.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia, Nasopharyngitis, Papule
Clinical narrative: Joint and muscle pain; Headache; Shoulder pain,joint pain; cold; Little Lump; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), PAPULE (Little Lump), HEADACHE (Headache), ARTHRALGIA (Shoulder pain,joint pain) and MYALGIA (Joint and muscle pain) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced NASOPHARYNGITIS (cold) and PAPULE (Little Lump). On 15-Mar-2021, the patient experienced HEADACHE (Headache) and ARTHRALGIA (Shoulder pain,joint pain). On 16-Mar-2021, the patient experienced MYALGIA (Joint and muscle pain). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Shoulder pain, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Headache, Shoulder pain and Muscle pain, at an unspecified dose and frequency. On 16-Mar-2021, NASOPHARYNGITIS (cold), PAPULE (Little Lump) and HEADACHE (Headache) had resolved. At the time of the report, ARTHRALGIA (Shoulder pain,joint pain) and MYALGIA (Joint and muscle pain) had not resolved.            Patient used warm compress as a corrective treatment for myalgia and arthralgia.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose after 42 days of 1st shot of Moderna Covid-19 Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose after 42 days of 1st shot of Moderna Covid-19 Vaccine) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic and Hypertensive.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose after 42 days of 1st shot of Moderna Covid-19 Vaccine). On 18-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose after 42 days of 1st shot of Moderna Covid-19 Vaccine) had resolved.       No concomitant medication were provided. No treatment details were provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-049573 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: No significant information was received. On 22-Jul-2021: No new information added.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Migraine, Nausea, Pyrexia
Clinical narrative: Fever; Chills; Headache; Nauseous; Lot of vomiting; Migraine; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nauseous) and VOMITING (Lot of vomiting) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergic asthma.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nauseous), VOMITING (Lot of vomiting) and MIGRAINE (Migraine). The patient was treated with DIMENHYDRINATE (DRAMAMINE) for Migraine, at an unspecified dose and frequency. On 27-Feb-2021, PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nauseous), VOMITING (Lot of vomiting) and MIGRAINE (Migraine) had resolved.            Concomitant medications included Vitamins  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Fever; Chills; Headache; Nauseous; Lot of vomiting; Migraine; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nauseous) and VOMITING (Lot of vomiting) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergic asthma.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nauseous), VOMITING (Lot of vomiting) and MIGRAINE (Migraine). The patient was treated with DIMENHYDRINATE (DRAMAMINE) for Migraine, at an unspecified dose and frequency. On 27-Feb-2021, PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nauseous), VOMITING (Lot of vomiting) and MIGRAINE (Migraine) had resolved.            Concomitant medications included Vitamins  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: Red patch on neck 2x4 inches in size; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red patch on neck 2x4 inches in size) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced ERYTHEMA (Red patch on neck 2x4 inches in size). At the time of the report, ERYTHEMA (Red patch on neck 2x4 inches in size) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact